David Hultsch / Holly Tuokko

Mild Cognitive Impairment

International Perspectives
Herausgeber: Tuokko, Holly A; Hultsch, David F

• Gebundenes Buch

Produktbeschreibung

Mild Cognitive Impairment (MCI) has been identified as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). Since treatments for AD are most likely to be most effective early in the course of the disease, MCI has become a topic of great importance and has been investigated in different populations of interest in many countries. This book brings together these differing perspectives on MCI for the first time. The introductory chapter is an overview of the evolving conceptions of cognitive change in later life and identifies the implicit and explicit assumptions underlying MCI research. The next two sections describe the findings emerging from studies conducted with different populations of interest (i.e., general population samples and specific samples) from different countries. Each chapter describes the types of information collected in the study, how MCI was defined, information pertaining to prevalence and incidence of MCI and important findings emerging from that study (e.g., Mayo Clinic, Kungsholmen Project, Melbourne Aging Study). The next section of the book describes the current status of intervention research for persons with MCI (e.g., pharmacologic, behavioral). A final chapter summarizes emerging trends in research on MCI and identifies promising areas for future research. This volume provides a comprehensive resource for clinicians, researchers, and students involved in the study, diagnosis, treatment, and rehabilitation of people with MCI

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 336
• Erscheinungstermin: 1. September 2006
• Englisch
• Abmessung: 243mm x 161mm x 26mm
• Gewicht: 676g
• ISBN-13: 9781841694665
• ISBN-10: 1841694665
• Artikelnr.: 21745911

Autorenporträt

Tuokko, Holly A.; Hultsch, David F.

Inhaltsangabe

Part 1. Introduction. H. Tuokko
I. McDowell
An Overview of Mild Cognitive Impairment. Part 2. General Population Research on MCI. C. Fabrigoule
P. Barberger-Gateau
J.-F. Dartigues
The PAQUID Study. K. Palmer
L. Bäckman
B.J. Small
L. Fratiglioni
Cognitive Impairment in Elderly Persons without Dementia: Findings from the Kungsholmen Project. J. Fleming
F.E. Matthews
M. Chatfield
C. Brayne
Population Levels of Mild Cognitive Impairment in England and Wales. A. Collie
P. Maruff
D.G. Darby
C. Masters
J. Currie
The Melbourne Aging Study. Part 3. Specific Samples. R. Wilson
N.T. Aggarwal
D.A. Bennett
Mild Cognitive Impairment in the Religious Orders Study. G. Smith
M. Machulda
K. Kantarci
A Perspective from the Mayo Clinic. M.C. Tierney
Prediction of Probable Alzheimer's Disease: The Sunnybrook Memory Study. H. Wolf
H.-J. Gertz
Studies in the Leipzig Memory Clinic: Contribution to the Concept of Mild Cognitive Impairment. Part 4. Interventions. H. Chertkow
Emerging Pharmacological Therapies for Mild Cognitive Impairment. B. Woods
L. Clare
Cognition-based Therapies and Mild Cognitive Impairment. K. Peters
G. Winocur
Combined Therapies in Mild Cognitive Impairment. Part 5. Summary and Future Directions. H. Tuokko
D.F. Hultsch
The Future of Mild Cognitive Impairment.